Mytos Announces $19M Series A Funding To Automate Human Cell Manufacturing And Further Accelerate Growth

Nov 30, 2023•over 1 year ago

Amount Raised

$19 Million

Round Type

series a

LondonBiotechnology

Investors

Wing VcIq CapitalBuckley Ventures

Description

Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC.

Company Information

Company

Mytos

Location

35111 NEWARK BLVD

London, England, United Kingdom

About

Mytos automates one of the last highly manual processes in biotech - growing human cells. Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data. Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL. We're hiring now- visit our website to see open positions

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech